683 Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$4.81 - $5.78 $1.03 Million - $1.24 Million
-215,000 Reduced 34.96%
400,000 $2.28 Million
Q1 2024

May 15, 2024
BUY
$4.93 - $9.31 $1.95 Million - $3.68 Million
395,000 Added 179.55%
615,000 $3.08 Million
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $1.57 Million - $2.09 Million
220,000 New
220,000 $1.98 Million

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email